title: Management of cancer-associated disseminated intravascular coagulation: guidance from the SSC of the ISTH.
authors.affiliation: Department of Haematology, Manchester Royal Infirmary, Manchester, UK.
authors.forename: J
authors.initials: J
authors.lastname: Thachil
authors.forename: A
authors.initials: A
authors.lastname: Falanga
authors.forename: M
authors.initials: M
authors.lastname: Levi
authors.forename: H
authors.initials: H
authors.lastname: Liebman
authors.forename: M
authors.initials: M
authors.lastname: Di Nisio
mesh_terms: D000933:Antifibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000187:drug effects*; D001780:Blood Coagulation Tests; D001803:Blood Transfusion / Q000592:standards*; D032921:Consensus; D004211:Disseminated Intravascular Coagulation / Q000097:blood / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D006801:Humans; D009369:Neoplasms / Q000097:blood / Q000150:complications*; D011237:Predictive Value of Tests; D012307:Risk Factors; D065227:Transfusion Reaction; D016896:Treatment Outcome; D016306:Vena Cava Filters / Q000592:standards
chemical_list: D000933:Antifibrinolytic Agents